Literature DB >> 36068473

Pharmacogenetics of Addiction Therapy.

David P Graham1, Mark J Harding1, David A Nielsen2.   

Abstract

Drug addiction is a serious relapsing disease that has high costs to society and to the individual addicts. Treatment of these addictions is still in its nascency, with only a few examples of successful therapies. Therapeutic response depends upon genetic, biological, social, and environmental components. A role for genetic makeup in the response to treatment has been shown for several addiction pharmacotherapies with response to treatment based on individual genetic makeup. In this chapter, we will discuss the role of genetics in pharmacotherapies, specifically for cocaine, alcohol, and opioid dependences. The continued elucidation of the role of genetics should aid in the development of new treatments and increase the efficacy of existing treatments.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Abuse; Addiction; Alcohol; Cocaine; Dependence; Drug; Gene; Opioid; Polymorphism; Therapy

Mesh:

Substances:

Year:  2022        PMID: 36068473     DOI: 10.1007/978-1-0716-2573-6_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  341 in total

Review 1.  Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.

Authors:  Mary Jeanne Kreek; David A Nielsen; Eduardo R Butelman; K Steven LaForge
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 2.  What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.

Authors:  David A Fishbain; Brandly Cole; John Lewis; Hubert L Rosomoff; R Steele Rosomoff
Journal:  Pain Med       Date:  2008 May-Jun       Impact factor: 3.750

3.  Factors associated with client-reported HIV infection among clients entering methadone treatment.

Authors:  R J MacGowan; R R Fichtner; N Swanson; C Collier; A Kroliczak; G Cole
Journal:  AIDS Educ Prev       Date:  1997-06

Review 4.  Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.

Authors:  Deborah L Zvosec; Stephen W Smith; Trinka Porrata; A Quinn Strobl; Jo Ellen Dyer
Journal:  Am J Emerg Med       Date:  2010-04-28       Impact factor: 2.469

5.  Annual Total Binge Drinks Consumed by U.S. Adults, 2015.

Authors:  Dafna Kanny; Timothy S Naimi; Yong Liu; Hua Lu; Robert D Brewer
Journal:  Am J Prev Med       Date:  2018-04       Impact factor: 5.043

6.  HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.

Authors:  B Meandzija; P G O'Connor; B Fitzgerald; B J Rounsaville; T R Kosten
Journal:  Drug Alcohol Depend       Date:  1994-10       Impact factor: 4.492

7.  Methadone-related deaths in Palm Beach County.

Authors:  Barbara C Wolf; Wendy A Lavezzi; Linda M Sullivan; Lisa M Flannagan
Journal:  J Forensic Sci       Date:  2004-03       Impact factor: 1.832

Review 8.  The Neuroscience of Drug Reward and Addiction.

Authors:  Nora D Volkow; Michael Michaelides; Ruben Baler
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

9.  Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States.

Authors:  Mandy Stahre; Jim Roeber; Dafna Kanny; Robert D Brewer; Xingyou Zhang
Journal:  Prev Chronic Dis       Date:  2014-06-26       Impact factor: 2.830

10.  A Substance Use Cost Calculator for US Employers With an Emphasis on Prescription Pain Medication Misuse.

Authors:  Eric Goplerud; Sarah Hodge; Tess Benham
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.